Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Turkey Aims To Bargain With Drug Firms To Ease Costs And Shortages

This article was originally published in PharmAsia News

Executive Summary

Turkey’s latest plan to ease shortages of mainly imported drugs for oncology and other chronic diseases while keeping a lid on reimbursement costs is to strike bargains with individual firms. But industry analysts are skeptical that systemic problems linked to exchange rate terms and growing demand will be solved by a new draft regulation allowing the Social Security Institution of Turkey, or SGK, to reach such deals.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts